Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 6 | 2018 | 302 | 1.570 |
Why?
|
| Maternal Deprivation | 3 | 2018 | 8 | 1.460 |
Why?
|
| Nicotinic Agonists | 5 | 2018 | 88 | 1.400 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2018 | 192 | 1.340 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2020 | 83 | 1.110 |
Why?
|
| Hippocampus | 5 | 2017 | 594 | 0.940 |
Why?
|
| Holoprosencephaly | 2 | 2015 | 5 | 0.930 |
Why?
|
| Behavior, Addictive | 2 | 2025 | 37 | 0.840 |
Why?
|
| Central Nervous System Depressants | 2 | 2020 | 42 | 0.760 |
Why?
|
| Impulsive Behavior | 3 | 2020 | 55 | 0.760 |
Why?
|
| Ethanol | 3 | 2020 | 224 | 0.750 |
Why?
|
| Secretory Vesicles | 3 | 2012 | 20 | 0.670 |
Why?
|
| Mood Disorders | 2 | 2018 | 54 | 0.670 |
Why?
|
| Octopodiformes | 1 | 2020 | 6 | 0.650 |
Why?
|
| Neprilysin | 1 | 2020 | 8 | 0.640 |
Why?
|
| Monoamine Oxidase | 1 | 2020 | 37 | 0.630 |
Why?
|
| Catecholamines | 1 | 2020 | 45 | 0.630 |
Why?
|
| CA3 Region, Hippocampal | 2 | 2016 | 7 | 0.620 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2017 | 26 | 0.610 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2017 | 48 | 0.610 |
Why?
|
| Receptors, GABA-A | 2 | 2017 | 65 | 0.600 |
Why?
|
| Locomotion | 1 | 2020 | 105 | 0.600 |
Why?
|
| Rats | 14 | 2020 | 3735 | 0.590 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2015 | 12 | 0.590 |
Why?
|
| Neurons | 6 | 2017 | 1263 | 0.560 |
Why?
|
| Behavior, Animal | 2 | 2020 | 373 | 0.550 |
Why?
|
| Cell Membrane | 2 | 2012 | 403 | 0.510 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 298 | 0.500 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 201 | 0.500 |
Why?
|
| Alleles | 1 | 2017 | 352 | 0.490 |
Why?
|
| Neurogenesis | 2 | 2013 | 63 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2018 | 1766 | 0.470 |
Why?
|
| Cranial Nerves | 1 | 2015 | 7 | 0.460 |
Why?
|
| Skull Base | 1 | 2015 | 5 | 0.460 |
Why?
|
| Trisomy | 1 | 2015 | 11 | 0.460 |
Why?
|
| Face | 1 | 2015 | 40 | 0.450 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 61 | 0.450 |
Why?
|
| Animals | 21 | 2020 | 16992 | 0.430 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 11 | 0.410 |
Why?
|
| Brain | 4 | 2018 | 1472 | 0.410 |
Why?
|
| Cholesterol | 3 | 2006 | 232 | 0.410 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 28 | 0.400 |
Why?
|
| Dentate Gyrus | 1 | 2013 | 40 | 0.400 |
Why?
|
| Maternal Exposure | 1 | 2013 | 57 | 0.380 |
Why?
|
| Aging | 2 | 2017 | 783 | 0.370 |
Why?
|
| Alcohol Drinking | 2 | 2017 | 609 | 0.350 |
Why?
|
| Astrocytes | 1 | 2013 | 244 | 0.350 |
Why?
|
| Receptors, AMPA | 1 | 2011 | 58 | 0.340 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 386 | 0.340 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 135 | 0.330 |
Why?
|
| Synapses | 1 | 2012 | 185 | 0.320 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 1001 | 0.310 |
Why?
|
| Stress, Psychological | 1 | 2016 | 661 | 0.310 |
Why?
|
| Reward | 2 | 2020 | 112 | 0.290 |
Why?
|
| Maze Learning | 2 | 2020 | 113 | 0.290 |
Why?
|
| Self Administration | 2 | 2020 | 69 | 0.270 |
Why?
|
| Conditioning, Operant | 2 | 2020 | 90 | 0.270 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 1998 | 140 | 0.270 |
Why?
|
| Phenylephrine | 5 | 1998 | 34 | 0.270 |
Why?
|
| Pregnancy | 4 | 2018 | 1772 | 0.260 |
Why?
|
| Dopamine | 2 | 2020 | 275 | 0.250 |
Why?
|
| Glutamate Decarboxylase | 2 | 2017 | 17 | 0.250 |
Why?
|
| Animals, Newborn | 3 | 2018 | 352 | 0.250 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2006 | 1 | 0.250 |
Why?
|
| Sterols | 1 | 2006 | 24 | 0.240 |
Why?
|
| Prefrontal Cortex | 3 | 2017 | 164 | 0.240 |
Why?
|
| Schizophrenia | 2 | 2017 | 93 | 0.240 |
Why?
|
| Receptors, Nicotinic | 2 | 2017 | 114 | 0.230 |
Why?
|
| Cadaver | 2 | 2015 | 40 | 0.230 |
Why?
|
| Pharmacogenetics | 1 | 2025 | 67 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 245 | 0.210 |
Why?
|
| Niemann-Pick Diseases | 1 | 2003 | 3 | 0.200 |
Why?
|
| Gangliosides | 1 | 2003 | 7 | 0.200 |
Why?
|
| Female | 9 | 2020 | 24698 | 0.200 |
Why?
|
| Male | 15 | 2020 | 23409 | 0.190 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 195 | 0.180 |
Why?
|
| Endothelin-1 | 2 | 1998 | 57 | 0.170 |
Why?
|
| Muscle Contraction | 4 | 1998 | 67 | 0.160 |
Why?
|
| Humans | 17 | 2025 | 43102 | 0.160 |
Why?
|
| Proteins | 1 | 2003 | 382 | 0.160 |
Why?
|
| RNA, Messenger | 3 | 2020 | 1271 | 0.160 |
Why?
|
| Spices | 1 | 2019 | 9 | 0.150 |
Why?
|
| Alternative Splicing | 2 | 2017 | 94 | 0.150 |
Why?
|
| Crocus | 1 | 2019 | 21 | 0.150 |
Why?
|
| Carotenoids | 1 | 2019 | 74 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 51 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 1998 | 39 | 0.140 |
Why?
|
| Sucrose | 1 | 2018 | 33 | 0.140 |
Why?
|
| Risk Factors | 2 | 2017 | 3994 | 0.140 |
Why?
|
| Schwann Cells | 1 | 1998 | 14 | 0.140 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 78 | 0.140 |
Why?
|
| Swimming | 1 | 2018 | 41 | 0.140 |
Why?
|
| Nerve Regeneration | 1 | 1998 | 46 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 65 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 118 | 0.130 |
Why?
|
| Nucleus Accumbens | 1 | 2017 | 100 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2017 | 58 | 0.130 |
Why?
|
| Antigens, Ly | 1 | 2016 | 8 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 70 | 0.120 |
Why?
|
| Vitamin B 12 | 1 | 2016 | 23 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2019 | 302 | 0.120 |
Why?
|
| Pyrroles | 1 | 2016 | 72 | 0.120 |
Why?
|
| Amygdala | 1 | 2016 | 125 | 0.110 |
Why?
|
| Pyrimidines | 1 | 2016 | 139 | 0.110 |
Why?
|
| Fetus | 1 | 2015 | 101 | 0.110 |
Why?
|
| Exocytosis | 2 | 2012 | 49 | 0.110 |
Why?
|
| Gestational Age | 1 | 2015 | 200 | 0.110 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 34 | 0.100 |
Why?
|
| Aorta | 2 | 1994 | 198 | 0.100 |
Why?
|
| Cell Count | 1 | 2013 | 145 | 0.100 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2013 | 35 | 0.100 |
Why?
|
| Serotonin | 1 | 1994 | 123 | 0.100 |
Why?
|
| Transcription Factors | 1 | 1998 | 735 | 0.100 |
Why?
|
| Gene Expression | 2 | 2017 | 701 | 0.090 |
Why?
|
| Genotype | 1 | 2015 | 800 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1994 | 131 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 587 | 0.090 |
Why?
|
| Time Factors | 2 | 2013 | 1857 | 0.090 |
Why?
|
| Penis | 4 | 1998 | 90 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 172 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2011 | 1621 | 0.090 |
Why?
|
| Body Weight | 1 | 2013 | 429 | 0.090 |
Why?
|
| trans-Golgi Network | 1 | 2011 | 4 | 0.090 |
Why?
|
| Cytoplasmic Granules | 1 | 2011 | 9 | 0.090 |
Why?
|
| Neuroendocrine Cells | 1 | 2011 | 4 | 0.090 |
Why?
|
| Mice | 5 | 2016 | 6644 | 0.090 |
Why?
|
| Synaptic Vesicles | 1 | 2011 | 31 | 0.080 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 149 | 0.080 |
Why?
|
| Anxiety | 1 | 2018 | 874 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2011 | 883 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2016 | 1035 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 734 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2017 | 2157 | 0.060 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2006 | 8 | 0.060 |
Why?
|
| Pancreas | 1 | 2006 | 45 | 0.060 |
Why?
|
| Muscle, Smooth | 2 | 1996 | 58 | 0.060 |
Why?
|
| Apoptosis | 1 | 2013 | 1568 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 1996 | 32 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 570 | 0.050 |
Why?
|
| PC12 Cells | 2 | 2016 | 93 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2025 | 408 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2025 | 149 | 0.050 |
Why?
|
| Histocytochemistry | 1 | 2003 | 47 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 83 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2017 | 972 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 26 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2003 | 21 | 0.050 |
Why?
|
| Antigens | 1 | 2003 | 59 | 0.050 |
Why?
|
| Vasoconstriction | 2 | 1993 | 42 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2003 | 53 | 0.050 |
Why?
|
| Intercellular Junctions | 2 | 1993 | 18 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 252 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 200 | 0.050 |
Why?
|
| Endocytosis | 1 | 2003 | 118 | 0.050 |
Why?
|
| Kinetics | 4 | 2003 | 695 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2017 | 1546 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 934 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 704 | 0.040 |
Why?
|
| Femoral Artery | 1 | 1998 | 12 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 1998 | 31 | 0.040 |
Why?
|
| Mesenteric Arteries | 1 | 1998 | 20 | 0.040 |
Why?
|
| Penile Erection | 2 | 1995 | 26 | 0.040 |
Why?
|
| Octamer Transcription Factor-6 | 1 | 1998 | 1 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 1998 | 12 | 0.040 |
Why?
|
| Hypertrophy | 1 | 1998 | 34 | 0.040 |
Why?
|
| Muscle Relaxation | 2 | 1995 | 19 | 0.030 |
Why?
|
| Child | 2 | 2017 | 3443 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 278 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1998 | 93 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 1998 | 46 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 1998 | 109 | 0.030 |
Why?
|
| Erectile Dysfunction | 2 | 1995 | 39 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 42 | 0.030 |
Why?
|
| Tubulin | 1 | 1998 | 96 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2017 | 93 | 0.030 |
Why?
|
| Axons | 1 | 1998 | 117 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 48 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 27 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2016 | 26 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 1994 | 258 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 1996 | 7 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2016 | 141 | 0.030 |
Why?
|
| Nitroglycerin | 1 | 1995 | 7 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 240 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 1998 | 665 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 6081 | 0.030 |
Why?
|
| Alcohols | 2 | 1993 | 14 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 213 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 490 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 526 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 196 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2017 | 430 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 758 | 0.030 |
Why?
|
| Reference Values | 1 | 1994 | 211 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2017 | 403 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1994 | 150 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1992 | 17 | 0.020 |
Why?
|
| Adult | 4 | 2017 | 13872 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2011 | 6 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2011 | 7 | 0.020 |
Why?
|
| Chromogranin A | 1 | 2011 | 7 | 0.020 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 7 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2011 | 40 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 1869 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 296 | 0.020 |
Why?
|
| Chromogranins | 1 | 2006 | 5 | 0.020 |
Why?
|
| Endocrine System | 1 | 2006 | 12 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 27 | 0.020 |
Why?
|
| Hormones | 1 | 2006 | 55 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2006 | 64 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 185 | 0.010 |
Why?
|
| Lipids | 1 | 2006 | 256 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 2003 | 27 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 2003 | 41 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 92 | 0.010 |
Why?
|
| Heptanol | 2 | 1993 | 2 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 296 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 508 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 189 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 532 | 0.010 |
Why?
|
| Aged | 3 | 1996 | 8214 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1995 | 2853 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1996 | 102 | 0.010 |
Why?
|
| Middle Aged | 3 | 1996 | 12222 | 0.010 |
Why?
|
| Oxymetazoline | 1 | 1993 | 2 | 0.010 |
Why?
|
| Diffusion | 1 | 1993 | 63 | 0.010 |
Why?
|
| Connexins | 1 | 1993 | 28 | 0.010 |
Why?
|
| Penile Diseases | 1 | 1992 | 6 | 0.010 |
Why?
|
| Transsexualism | 1 | 1992 | 20 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1992 | 92 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1992 | 575 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1996 | 539 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1993 | 561 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1992 | 760 | 0.000 |
Why?
|